Furthermore, AM-MSC-EVs significantly prevented HSCs and KCs activation and amended the degree of hepatocyte inflammation and fibrogenesis in NASH through affecting LPS/ Toll-like receptor 4 (TLR4) pathway (Ohara et al. 2018). The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatohepatitis.